Eone Diagnomics Genome Center Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 117.82 million compared to KRW 33.35 million a year ago. Net income was KRW 189.61 million compared to net loss of KRW 5,573.13 million a year ago.

Basic earnings per share from continuing operations was KRW 2 compared to basic loss per share from continuing operations of KRW 68 a year ago. Basic earnings per share was KRW 2 compared to basic loss per share of KRW 68 a year ago.